Skip to content

Clinical trials

Withdrawn Phase 2 Diabetes Mellitus, Type 2 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Status: Withdrawn Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20111
20123
20131
20152
20161
20171
20192
20211
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
Eli Lilly and Company2
Albert Einstein College of Medicine1
Amgen1
Boston Therapeutics1
George Medicines PTY Limited1
Halia Therapeutics, Inc.1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1
Laboratorios Silanes S.A. de C.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 223
Obesity4
Diabetes Mellitus3
Insulin Resistance3
Non-alcoholic Fatty Liver Disease3
Glucose Intolerance2
Hypertension2
Overweight2
Arthritis, Psoriatic1
Diabetic Nephropathies1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.